Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | AZN:LSE since announced | Transaction value |
---|---|---|
Fusion Pharmaceuticals Inc | 10.32% | 2.30bn |
Amolyt Pharma SAS | 8.55% | 1.05bn |
Gracell Biotechnologies Inc | 8.78% | 1.10bn |
Icosavax Inc | 12.44% | 862.87m |
Data delayed at least 20 minutes, as of Apr 24 2024 18:09 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 Dec 2023 | 272.11k | 0.00% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.